关节镜下上盂肱二头肌腱固定术与切开胸大肌下二头肌腱固定术中期随访临床结局无差异:一项随机前瞻性分析
这项随机对照试验将85例因肱二头肌长头腱病变行腱固定术的患者随机分为关节镜下上盂肱二头肌腱固定术组与切开胸大肌下二头肌腱固定术组,两组均使用聚醚醚酮干涉螺钉固定。最终73例完成至少24个月随访,结果显示两组在ASES、Constant主观和SANE评分及并发症率上均无显著差异。
要点
- 关节镜下上盂肱二头肌腱固定术与切开胸大肌下二头肌腱固定术在至少2年随访时患者报告结局无显著差异。
- 两组ASES评分P=0.25、Constant主观评分P=0.52、SANE评分P=0.61,均无统计学显著差异。
- 两组均无患者需要翻修肱二头肌腱固定术。
核心结论
- 在至少2年随访中,关节镜下上盂肱二头肌腱固定术与切开胸大肌下二头肌腱固定术在患者报告结局和并发症率方面各时间点均无显著差异。
研究设计与样本
- 随机对照试验,证据等级1级;85例因肱二头肌长头腱疾病行肱二头肌腱固定术的患者随机分为关节镜下上盂肱二头肌腱固定术组或切开胸大肌下二头肌腱固定术组,两组均使用聚醚醚酮干涉螺钉固定。
主要发现
- 最终73例纳入临床结局分析(关节镜下上盂肱二头肌腱固定术组37/42例[88%],切开胸大肌下二头肌腱固定术组36/42例[86%]),平均年龄50.4±10.3岁,平均体重指数29±7.9。
- 平均最终随访2.9年(关节镜下上盂肱二头肌腱固定术组3年,切开胸大肌下二头肌腱固定术组2.8年[范围2-5.2年])。
- 最终随访时ASES评分(P=0.25)、Constant主观评分(P=0.52)和SANE评分(P=0.61)均无统计学显著差异。
- 从平均12.6个月至最终随访34.5个月,临床结局评分无显著改善(关节镜下上盂肱二头肌腱固定术组:ASES P=0.43、Constant P=0.25、SANE P=0.45;切开胸大肌下二头肌腱固定术组:ASES P=0.65、Constant P=0.78、SANE P=0.70)。
- 两组均无患者需要翻修肱二头肌腱固定术。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We have previously reported the 1-year outcomes of arthroscopic suprapectoral biceps tenodesis (ASPBT) versus open subpectoral biceps tenodesis (OSPBT) for the management of long head of the biceps tendon (LHBT) pathology. While patients had similar 1-year biceps muscle strength and pain, longer-term functional outcomes are unknown. PURPOSE: To directly compare clinical outcomes of ASPBT versus OSPBT with interference screw fixation, distal to the bony bicipital groove, at a minimum of 2 years' follow-up. STUDY DESIGN: Randomized controlled trial; Level of evidence, 1. METHODS: A total of 85 patients undergoing biceps tenodesis (BT) for LHBT disease were randomized into the ASPBT or OSPBT group. Both techniques utilized polyether ether ketone inference screws for tenodesis fixation. Patients completed American Shoulder and Elbow Surgeons (ASES), Constant subjective, and Single Assessment Numeric Evaluation (SANE) questionnaires preoperatively and again at 6 months, 12 months, and at the final follow-up at a minimum of 24 months. RESULTS: A total of 73 patients (37/42 randomized to ASPBT [88%]; 36/42 randomized to OSPBT [86%]) with a mean age of 50.4 ± 10.3 years and a mean body mass index of 29 ± 7.9 were included in clinical outcome analyses. The mean final follow-up was 2.9 years (ASPBT, 3 years; OSPBT, 2.8 years [range 2-5.2 years]). Comparison of demographic characteristics and intraoperative findings showed no significant differences in age, sex, concomitant procedures, and rotator cuff disease. No statistically significant differences in the ASES (P = .25), Constant subjective (P = .52), and SANE scores (P = .61) were found at the final follow-up. Clinical outcomes scores showed no significant improvement from a mean of 12.6 months to the final follow-up at 34.5 months (ASPBT: ASES, P = .43; Constant, P = .25; SANE, P = .45 vs OSPBT: ASES, P = .65; Constant, P = .78; SANE, P = .70). No patients required revision of BT in either group. CONCLUSION: This study reported a minimum of 2-year follow-up of patients undergoing ASPBT or OSPBT, utilizing the same interference screw technique, for the management of LHBT pathology in the setting of concomitant shoulder procedures. There were no significant differences in patient-reported outcomes and complication rates found at any time point. REGISTRATION: NCT02192073 (ClinicalTrials.gov identifier).
引用
- Forsythe B, Berlinberg EJ, Diaz CC, et al. No Difference in Clinical Outcomes for Arthroscopic Suprapectoral Versus Open Subpectoral Biceps Tenodesis at Midterm Follow-up: A Randomized Prospective Analysis. Am J Sports Med. 2022. PMID: 35507468. doi:10.1177/03635465221084731
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。